1. Home
  2. TOVX vs TTEC Comparison

TOVX vs TTEC Comparison

Compare TOVX & TTEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TOVX
  • TTEC
  • Stock Information
  • Founded
  • TOVX 2001
  • TTEC 1982
  • Country
  • TOVX United States
  • TTEC United States
  • Employees
  • TOVX N/A
  • TTEC N/A
  • Industry
  • TOVX Biotechnology: Pharmaceutical Preparations
  • TTEC Retail: Computer Software & Peripheral Equipment
  • Sector
  • TOVX Health Care
  • TTEC Technology
  • Exchange
  • TOVX Nasdaq
  • TTEC Nasdaq
  • Market Cap
  • TOVX 3.8M
  • TTEC 264.5M
  • IPO Year
  • TOVX 2006
  • TTEC 1996
  • Fundamental
  • Price
  • TOVX $0.48
  • TTEC $5.07
  • Analyst Decision
  • TOVX Hold
  • TTEC Hold
  • Analyst Count
  • TOVX 1
  • TTEC 3
  • Target Price
  • TOVX N/A
  • TTEC $9.75
  • AVG Volume (30 Days)
  • TOVX 172.2K
  • TTEC 267.3K
  • Earning Date
  • TOVX 08-12-2025
  • TTEC 08-07-2025
  • Dividend Yield
  • TOVX N/A
  • TTEC N/A
  • EPS Growth
  • TOVX N/A
  • TTEC N/A
  • EPS
  • TOVX N/A
  • TTEC N/A
  • Revenue
  • TOVX N/A
  • TTEC $2,165,177,000.00
  • Revenue This Year
  • TOVX N/A
  • TTEC N/A
  • Revenue Next Year
  • TOVX N/A
  • TTEC N/A
  • P/E Ratio
  • TOVX N/A
  • TTEC N/A
  • Revenue Growth
  • TOVX N/A
  • TTEC N/A
  • 52 Week Low
  • TOVX $0.40
  • TTEC $3.11
  • 52 Week High
  • TOVX $7.37
  • TTEC $8.45
  • Technical
  • Relative Strength Index (RSI)
  • TOVX 49.42
  • TTEC 53.36
  • Support Level
  • TOVX $0.42
  • TTEC $5.04
  • Resistance Level
  • TOVX $0.48
  • TTEC $5.48
  • Average True Range (ATR)
  • TOVX 0.03
  • TTEC 0.22
  • MACD
  • TOVX 0.02
  • TTEC 0.01
  • Stochastic Oscillator
  • TOVX 78.22
  • TTEC 58.44

About TOVX Theriva Biologics Inc.

Theriva Biologics Inc is a clinical-stage pharmaceutical company developing a novel oncolytic adenovirus (OV) platform to address devastating cancers with high unmet needs. It is a lead clinical-stage program VCN-01, designed to break down the tumor stroma, and its preclinical-stage program VCN-11 leverages its proprietary Albumin Shield Technology to protect systemically administered oncolytic viruses from the host immune system.

About TTEC TTEC Holdings Inc.

TTEC Holdings Inc provides customer engagement management tools and services. The company operates through four operating segments that are organized into two groups, TTEC Digital and TTEC Engage. TTEC Digital is engaged in building and implementing cloud-based and on-premises customer experience tools that enable clients to develop customer engagement strategies. TTEC Engage focuses on delivering sales and marketing solutions to help clients boost their revenue as well as on managing customer's front-to-back office processes to optimize the customer experience. TTEC Engage contributes the vast majority of the company's revenue, and its sales are derived from the United States and Canada, followed by Philippines, Asia-Pacific and India.

Share on Social Networks: